Cite
Sommerburg O, Hämmerling S, Schneider SP, et al. CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis. Antioxidants (Basel). 2021;10(3)doi: 10.3390/antiox10030483.
Sommerburg, O., Hämmerling, S., Schneider, S. P., Okun, J., Langhans, C. D., Leutz-Schmidt, P., Wielpütz, M. O., Siems, W., Gräber, S. Y., Mall, M. A., & Stahl, M. (2021). CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis. Antioxidants (Basel, Switzerland), 10(3), . https://doi.org/10.3390/antiox10030483
Sommerburg, Olaf, et al. "CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis." Antioxidants (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/antiox10030483
Sommerburg O, Hämmerling S, Schneider SP, Okun J, Langhans CD, Leutz-Schmidt P, Wielpütz MO, Siems W, Gräber SY, Mall MA, Stahl M. CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis. Antioxidants (Basel). 2021 Mar 19;10(3). doi: 10.3390/antiox10030483. PMID: 33808590; PMCID: PMC8003491.
Copy
Download .nbib